Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials
Deucravacitinib治疗斑块状银屑病:POETYK PSO-1、PSO-2 和长期扩展试验的3期安全性和有效性结果
期刊:Journal of the European Academy of Dermatology and Venereology
影响因子:8
doi:10.1111/jdv.20553
Armstrong, April W; Lebwohl, Mark; Warren, Richard B; Sofen, Howard; Morita, Akimichi; Paul, Carle; Papp, Kim A; Colombo, Matthew J; Scotto, Julie; Vaile, John; Zhuo, Joe; Vritzali, Eleni; Berger, Victoria; Schroeder, Georgene; Banerjee, Subhashis; Thaçi, Diamant; Strober, Bruce